Home › Esophageal Adenocarcinoma › Nevada › Las Vegas
Esophageal Adenocarcinoma clinical trials in Las Vegas, NV
4 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- OptumCare Cancer Care at Charleston, Las Vegas
- OptumCare Cancer Care at Fort Apache, Las Vegas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- OptumCare Cancer Care at Charleston, Las Vegas
- University Medical Center of Southern Nevada, Las Vegas
- Hope Cancer Care of Nevada, Las Vegas
- and 16 more
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Comprehensive Cancer Center of Nevada, Las Vegas
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Comprehensive Cancer Centers of Nevada, Las Vegas
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Nashville, TN11 studies
- Arlington, VA11 studies
- Durham, NC10 studies
- St. Louis, MO9 studies
- Baldwin Park, CA9 studies
- Jacksonville, FL9 studies
- Rochester, MN9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Las Vegas
- Obesity27 studies
- Overweight23 studies
- Type 2 Diabetes18 studies
- Non-Small Cell Lung Cancer13 studies
- Major Depressive Disorder13 studies
- Breast Cancer10 studies
- Alzheimer's Disease8 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Cancer (all types)8 studies
- Schizophrenia7 studies
- Atherosclerosis7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.